{"SPADE_UN_17359": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17359", "Peptide Name": "Trichogin GA IV Ome", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "XGLXGGLXGI", "Sequence Length": 10, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "C8", "C-terminal Modification": "OMe", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C26H41N7O5", "Mass": 102238, "PI": 6.11, "Net Charge": 0, "Hydrophobicity": 1.05, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Literature": [{"Title": "The peculiar N- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity.", "Pubmed ID": "25306964", "Reference": "Biochim Biophys Acta. 2015 Jan;1848(1 Pt A)134-44.", "Author": "Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=25306964"}, {"Title": "The peculiar n- and (-termini of trichogin GA IV are needed for membrane interaction and human cell death induction at doses lacking antibiotic activity", "Pubmed ID": "", "Author": "Tavano R, Malachin G, De Zotti M, Peggion C, Biondi B, Forrnaggio F, Papini E"}], "Frequent Amino Acids": "GXL", "Absent Amino Acids": "ACDEFHKMNOPQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 3, "Polar Residues": 0, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_07328", "Similarity": 1.0, "Sequence": "GLGGLGIL"}, {"SPADE_ID": "SPADE_N_09582", "Similarity": 1.0, "Sequence": "GGLGIL"}, {"SPADE_ID": "SPADE_N_15741", "Similarity": 1.0, "Sequence": "GLGGLGI"}]}}}